S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

CureVac (CVAC) Short Interest Ratio & Short Volume

$2.44
0.00 (0.00%)
(As of 04/19/2024 ET)

CureVac Short Interest Data

Current Short Volume
5,010,000 shares
Previous Short Volume
4,860,000 shares
Change Vs. Previous Month
+3.09%
Dollar Volume Sold Short
$15.18 million
Short Interest Ratio / Days to Cover
6.1
Last Record Date
March 31, 2024
Outstanding Shares
223,880,000 shares
Float Size
91,600,000 shares
Short Percent of Float
5.47%
Today's Trading Volume
793,106 shares
Average Trading Volume
738,494 shares
Today's Volume Vs. Average
107%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling CureVac ?

Sign up to receive the latest short interest report for CureVac and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CVAC Short Interest Over Time

CVAC Days to Cover Over Time

CVAC Percentage of Float Shorted Over Time

CureVac Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20245,010,000 shares $15.18 million +3.1%5.5%6.1 $3.03
3/15/20244,860,000 shares $16.04 million +10.7%5.3%5.5 $3.30
2/29/20244,390,000 shares $15.01 million +3.1%4.8%3.5 $3.42
2/15/20244,260,000 shares $14.74 million +2.9%4.7%3.6 $3.46
1/31/20244,140,000 shares $14.86 million -1.2%4.5%3.7 $3.59
1/15/20244,190,000 shares $16.26 million +1.7%4.6%4 $3.88
12/31/20234,120,000 shares $17.35 million +9.9%4.5%4.1 $4.21
12/15/20233,750,000 shares $22.95 million -11.6%4.1%3.7 $6.12
11/30/20234,240,000 shares $22.90 million +2.7%4.6%8.8 $5.40
11/15/20234,130,000 shares $22.84 million -3.7%4.5%9.5 $5.53
10/31/20234,290,000 shares $22.74 million +1.7%4.7%9.3 $5.30
10/15/20234,220,000 shares $25.02 million +1.0%4.6%9.6 $5.93
9/30/20234,180,000 shares $28.55 million -8.5%4.6%9.3 $6.83
9/15/20234,570,000 shares $36.61 million -7.7%5.0%10.8 $8.01
8/31/20234,950,000 shares $44.20 million +2.1%5.4%8.8 $8.93
8/15/20234,850,000 shares $44.86 million +0.2%5.3%7.5 $9.25
7/31/20234,840,000 shares $44.92 million -1.6%5.3%7.2 $9.28
7/15/20234,920,000 shares $48.66 million +12.3%5.4%7.1 $9.89
6/30/20234,380,000 shares $45.64 million +5.0%4.8%6.6 $10.42
6/15/20234,170,000 shares $41.45 million -0.7%4.5%6.7 $9.94
5/31/20234,200,000 shares $40.53 million -2.6%4.5%8.1 $9.65
5/15/20234,310,000 shares $38.40 million +19.4%4.6%7.7 $8.91
4/30/20233,610,000 shares $26.61 million -11.5%3.9%4.9 $7.37
4/15/20234,080,000 shares $31.78 million -0.7%4.5%5.1 $7.79
3/31/20234,110,000 shares $28.65 million +13.5%4.5%3.5 $6.97
3/15/20233,620,000 shares $25.34 million +2.8%4.0%3 $7.00
2/28/20233,520,000 shares $30.41 million +11.0%3.9%2.9 $8.64
2/15/20233,170,000 shares $28.09 million -26.3%4.8%2.7 $8.86
1/31/20234,300,000 shares $46.18 million No Change7.6%3.8 $10.74
1/15/20234,300,000 shares $44.03 million +75.5%7.6%5 $10.24
12/30/20222,450,000 shares $14.77 million +20.7%4.4%3.8 $6.03
12/15/20222,030,000 shares $13.74 million -2.9%3.6%4.8 $6.77
11/30/20222,090,000 shares $15.15 million -7.5%2.9%6.1 $7.25
11/15/20222,260,000 shares $18.24 million -13.4%3.2%6.7 $8.07
10/31/20222,610,000 shares $19.00 million -3.0%4.8%8.7 $7.28
10/15/20222,690,000 shares $20.23 million -5.9%4.9%8.6 $7.52
9/30/20222,860,000 shares $22.54 million -17.3%5.3%8.7 $7.88
9/15/20223,460,000 shares $33.35 million +5.2%6.4%7.1 $9.64
8/31/20223,290,000 shares $32.37 million +6.1%6.1%6.3 $9.84
8/15/20223,100,000 shares $41.48 million +5.4%5.8%5.3 $13.38
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

CVAC Short Interest - Frequently Asked Questions

What is CureVac's current short interest?

Short interest is the volume of CureVac shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 5,010,000 shares of CVAC short. 5.47% of CureVac's shares are currently sold short. Learn More on CureVac's current short interest.

What is a good short interest ratio for CureVac?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CVAC shares currently have a short interest ratio of 6.0. Learn More on CureVac's short interest ratio.

Which institutional investors are shorting CureVac?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CureVac: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for CureVac?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.47% of CureVac's floating shares are currently sold short.

Is CureVac's short interest increasing or decreasing?

CureVac saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 5,010,000 shares, an increase of 3.1% from the previous total of 4,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is CureVac's float size?

CureVac currently has issued a total of 223,880,000 shares. Some of CureVac's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CureVac currently has a public float of 91,600,000 shares.

How does CureVac's short interest compare to its competitors?

5.47% of CureVac's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CureVac: Verve Therapeutics, Inc. (28.03%), Mineralys Therapeutics, Inc. (4.82%), Korro Bio, Inc. (2.31%), Olema Pharmaceuticals, Inc. (14.48%), Phathom Pharmaceuticals, Inc. (39.95%), Astria Therapeutics, Inc. (11.37%), Nuvation Bio Inc. (2.10%), Lyell Immunopharma, Inc. (15.53%), GH Research PLC (4.47%), AnaptysBio, Inc. (18.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short CureVac stock?

Short selling CVAC is an investing strategy that aims to generate trading profit from CureVac as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CureVac?

A short squeeze for CureVac occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CVAC, which in turn drives the price of the stock up even further.

How often is CureVac's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CVAC, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CVAC) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners